ARCHIVES

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

ACS Seeks Applications For Clinical Awards

January 1, 1993

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

NCI Advisors Approve Research Network On Screening

August 6, 2010

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005